Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Papillomavirus Infections 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Mouth Diseases 1Kidney Neoplasms 1Hematuria 1Endometrial Neoplasms 1Carcinoma, Transitional Cell 1Anus Neoplasms 1

Interventions

pembrolizumab 21enfortumab vedotin 13Gemcitabine 12Nivolumab 8Cisplatin 8Carboplatin 8Magnetic Resonance Spectroscopy 6Specimen Handling 5Docetaxel 5toripalimab 4sacituzumab govitecan 4Paclitaxel 4Ipilimumab 4atezolizumab 3Mitomycin 3Fluorouracil 3disitamab vedotin 2cabozantinib 2avelumab 2Radiosurgery 2Platinum 2Injections 2Immunotherapy 2Fluorodeoxyglucose F18 2Cyclophosphamide 2Biopsy 2zanidatamab 1tremelimumab 1tamibarotene 1talazoparib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Carcinoma, Transitional Cell × Cytological Techniques × Clear all
NCT07037589 2025-11-21

BLUSH

Vastra Gotaland Region

Recruiting
300 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Hematuria, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡